Form 8-K - Current report:
SEC Accession No. 0000950170-23-027292
Filing Date
2023-06-09
Accepted
2023-06-09 17:00:58
Documents
12
Period of Report
2023-06-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20230608.htm   iXBRL 8-K 57673
  Complete submission text file 0000950170-23-027292.txt   172507

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20230608.xsd EX-101.SCH 2481
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20230608_pre.xml EX-101.PRE 9461
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20230608_lab.xml EX-101.LAB 12806
6 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20230608_htm.xml XML 4550
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 231006164
SIC: 2836 Biological Products, (No Diagnostic Substances)